This study is testing a new device called Fecobionics to better understand and treat constipation caused by dyssynergia (a problem with muscle coordination during bowel movements). The Fecobionics device is inserted into the rectum to collect detailed information about how your body works during defecation. Researchers hope this information will help predict who will benefit most from biofeedback therapy, a treatment for dyssynergia. You may be able to join if you are between 21 and 75 years old, have been diagnosed with obstructed defecation/dyssynergia, and are starting biofeedback therapy at UCSD or Scripps. The study aims to see how long it takes to expel the device and measure pressure differences within it after 1.5 years.

Study design

This is an interventional study with a planned enrollment of 24 participants. The study aims to monitor and predict biofeedback therapy outcomes using a new medical device.

What's involved

You will have the Fecobionics device inserted into your rectum, and you will be asked to perform actions like coughing, squeezing, or pushing. This will happen before, during, and after biofeedback therapy.

Compensation

Not stated in the trial record.

Follow-up

The primary outcomes, expulsion duration and pressure difference, will be measured at 1.5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.